Rachel Haurwitz, Caribou CEO (Kimberly White/Getty Images for TechCrunch)
March 3, 2021 08:00 AM ESTUpdated 09:16 AM
Financing

A Jen­nifer Doud­na-launched up­start nabs $115M for off-the-shelf CAR-Ts

Nicole DeFeudis

Editor

There is no short­age of biotechs pur­su­ing off-the-shelf CAR-Ts, a so-called Holy Grail in on­col­o­gy R&D. Now, less than a month af­ter team­ing up with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Will CRISPR mat­ter?

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times